CIK 0001894562 · <br>Emerging growth company
Prime Medicine, Inc.
Sign in to watch- Ticker
- PRME
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-465-0013
- Business address
- 60 FIRST ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-21 | Alenson Carman See Remarks | Grant or award · Stock Option (right to buy) | +90,498 | 90,498 | ||
| 2024-02-15 | NELSEN ROBERT Director | Purchase | +3,200,000 | $6.25 | $20.0M | 3,200,000 |
| 2024-02-15 | ARCH Venture Partners XII, LLC 10% owner | Purchase | +3,200,000 | $6.25 | $20.0M | 3,200,000 |
| 2024-02-15 | ARCH Venture Partners X, LLC 10% owner | Purchase | +3,200,000 | $6.25 | $20.0M | 3,200,000 |
| 2024-01-17 | Reine Allan Chief Financial Officer | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2023-11-11 | Gottesdiener Keith Michael See Remarks | Gift | −7,500 | 2,560,837 | ||
| 2023-11-11 | Gottesdiener Keith Michael See Remarks | Gift | −5,000 | 27,166 | ||
| 2023-07-21 | Liu David R. 10% owner | Gift | −1,000,000 | 20,156,945 | ||
| 2023-07-21 | Liu David R. 10% owner | Gift | −1,000,000 | 20,156,945 | ||
| 2023-06-21 | GV 2019 GP, L.L.C. 10% owner | Other disposition 10b5-1 | −19,003 | 10,100,058 | ||
| 2023-06-21 | GV 2019 GP, L.L.C. 10% owner | Sale 10b5-1 | −19,003 | $14.97 | $284K | 0 |
| 2023-06-20 | GV 2019 GP, L.L.C. 10% owner | Other disposition 10b5-1 | −37,405 | 10,119,061 | ||
| 2023-06-20 | GV 2019 GP, L.L.C. 10% owner | Sale 10b5-1 | −37,405 | $15.06 | $563K | 0 |
| 2023-06-16 | GV 2019 GP, L.L.C. 10% owner | Other disposition 10b5-1 | −6,532 | 10,156,466 | ||
| 2023-06-16 | GV 2019 GP, L.L.C. 10% owner | Sale 10b5-1 | −6,532 | $15.02 | $98K | 0 |
| 2023-06-15 | GV 2019 GP, L.L.C. 10% owner | Other disposition 10b5-1 | −66,659 | 10,162,998 | ||
| 2023-06-15 | GV 2019 GP, L.L.C. 10% owner | Sale 10b5-1 | −66,659 | $14.92 | $994K | 0 |
| 2023-06-14 | Cahill Thomas Director | Grant or award · Stock Option (right to buy) | +39,062 | 39,062 | ||
| 2023-06-14 | Schenkein David P Director | Grant or award · Stock Option (right to buy) | +39,062 | 39,062 | ||
| 2023-06-14 | Foster-Cheek Kaye I Director | Grant or award · Stock Option (right to buy) | +39,062 | 39,062 |
Page 7 of 13 · 241 trades